Skip to content

Infex Therapeutics Holdings PLC

ActivePublic limited company

Key figures

Year to 31 Jul 2026

Loss
£231k+£17.2mon prior year
Net assets
£6m+£4.2mon prior year
Total assets
£6m+£2.6mon prior year
Cash at bank
£1m−£385.4kon prior year
Employees
0
Balance sheetLast 4 filed years
Total assets, 2023: £6.6mTotal assets, 2024: £11mTotal assets, 2025: £3.4mTotal assets, 2026: £6mNet assets, 2023: £2.7mNet assets, 2024: £2.6mNet assets, 2025: £1.8mNet assets, 2026: £6mTotal liabilities, 2023: £3.9mTotal liabilities, 2024: £8.4mTotal liabilities, 2025: £1.7mTotal liabilities, 2026: £9k2023202420252026
  • Total assets£6m
  • Net assets£6m
  • Total liabilities£9k

From accounts filed with Companies House · FRS 102 accounts. Changes are against the prior year.

Accounts

Current period

9 months left

1 Aug 202631 Jul 2027
Next accounts due
31 Jan 2028
in 15 months
Last made up to
31 Jul 2026

Past periods

  • 1 Aug 2025 – 31 Jul 2026
  • 1 Aug 2024 – 31 Jul 2025

Details

Company number
13917179
Incorporated
15 February 2022
Registered office
1 Bow Churchyard, London, EC4M 9DQ, United Kingdom
Nature of business
  • Activities of other holding companies n.e.c. 64209
Directors
  • Dr Peter Jackson
  • Christopher Doherty
  • Jonathan Paul Moulton
  • Professor Colm Leonard
Board mix
  • 3 men
  • 1 not known

Estimated from directors’ names.

See the full picture of Infex Therapeutics Holdings PLC

  • Financials, year by year
  • Filed accounts and documents
  • Ownership chart
Create a free account

Free, with 3 credits a month.

From Companies House, updated 26 Feb 2026.